MALVERN, Pa. & MONTREAL--(BUSINESS WIRE)--Gemin X Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on developing novel treatments for cancer, is pleased to announce the appointment of Eric W. Roberts to its Board of Directors.
